Interleukin-24 Induces Neuroblastoma SH-SY5Y cell differentiation, growth inhibition, and apoptosis by promoting ROS production

Journal of Interferon and Cytokine Research

Volumn 33, Issue 11, 2013, Pages 709-714

  Li, Yuan ^a   Zhang, Hongwei ^a   Zhu, Xiaoyu ^a   Feng, Dongchuan ^a   Gong, Jinchao ^a   Han, Tao ^a  

^a XUZHOU CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 24; REACTIVE OXYGEN METABOLITE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; CELL DIFFERENTIATION; CELL SURVIVAL; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; INTERLEUKINS; NEUROBLASTOMA; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 84887072325     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0004     Document Type: Article

References (28)

1. Bauters TG, Laureys G, Van de Velde V, Benoit Y, Robays H. 2011. Practical implications for the administration of 13-cis retinoic acid in pediatric oncology. Int J Clin Pharm 33(4):597-598.
2. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S, Grimm EA. 2002. The protein product of the tumor suppressor gene, melanoma differentiation-Associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 168(12):6041-6046.
3. Cheung R. 2012. Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: A US SEER Data Analysis. Asian Pac J Cancer Prev 13(9):4587-4591.
4. Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel DT, Fisher PB. 2010. mda-7/IL-24: a unique member of the IL- 10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev 21(5):381-391.
5. DE Ioris MA, Contoli B, Jenkner A, DE Pasquale MD, Serra A, DE Sio L, Pessolano R, Garganese MC, Crocoli A, Corneli T, Boldrini R, Castellano A. 2012. Comparison of two different conditioning regimens before autologous transplantation for children with high-risk neuroblastoma. Anticancer Res 32(12): 5527-5533.
6. Dent P, Yacoub A, Hamed HA, Park MA, Dash R, Bhutia SK, Sarkar D, Wang XY, Gupta P, Emdad L, Lebedeva IV, Sauane M, Su ZZ, Rahmani M, Broaddus WC, Young HF, Lesniak MS, Grant S, Curiel DT, Fisher PB. 2010. The development of MDA-7/IL-24 as a cancer therapeutic. Pharmacol Ther 128(2):375-384.
7. Finkel T. 1999. Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 65(3):337-340.
8. Hobbie WL, Moab SM, Carlson CA, Gruccio D, Ginsberg JP. 2011. Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma. Pediatr Blood Cancer 56(3):474-476.
9. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB. 2001. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20(48):7051-7063.
10. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. 1995. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11(12): 2477-2486.
11. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. 2009. Oxidative stress in prostate cancer. Cancer Lett 282(2):125-136.
12. Lebedeva IV, Su ZZ, Vozhilla N, Chatman L, Sarkar D, Dent P, Athar M, Fisher PB. 2008. Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiationassociated gene-7/interleukin-24 and perillyl alcohol. Cancer Res 68(18):7439-7447.
13. Lev N, Melamed E, Offen D. 2006. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Neurosci Lett 399(1-2):27-32.
14. Margue C, Kreis S. 2010. IL-24: physiological and supraphysiological effects on normal and malignant cells. Curr Med Chem 17(29):3318-3326.
15. Maris JM. 2010. Recent advances in neuroblastoma. N Engl J Med 362(23):2202-2211.
16. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG. 2009. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a childrens oncology group study. J Clin Oncol 27(7):1007-1013.
17. Nitti M, Furfaro AL, Traverso N, Odetti P, Storace D, Cottalasso D, Pronzato MA, Marinari UM, Domenicotti C. 2007. PKC delta and NADPH oxidase in AGE-induced neuronal death. Neurosci Lett 416(3):261-265.
18. Park MA, Yacoub A, Sarkar D, Emdad L, Rahmani M, Spiegel S, Koumenis C, Graf M, Curiel DT, Grant S, Fisher PB, Dent P. 2008. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy 4(4): 513-515.
19. Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. 2008. Development of Ad-mda7/IL-24-resistant lung cancer cell lines. Cancer Biol Ther 7(1):103-108.
20. Sarkar D, Lebedeva IV, Gupta P, Emdad L, Sauane M, Dent P, Curiel DT, Fisher PB. 2007. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a magic bullet for cancer therapy? Expert Opin Biol Ther 7(5):577-586.
21. Sauer H, Wartenberg M, Hescheler J. 2001. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11(4):173-186.
22. Schor NF. 1999. Neuroblastoma as a neurobiological disease. J Neurooncol 41(2):159-166.
23. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Wart Hood J, Merritt J, Chada S. 2005. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanomadifferentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 11(1):160-172.
24. Tsukagoshi H, Busch W, Benfey PN. 2010. Transcriptional regulation of ROS controls transition from proliferation to differentiation in the root. Cell 143(4):606-616.
25. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, Reynolds CP. 1995. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 13(4):894-901.
26. Yan S, Zhang H, Xie Y, Sheng W, Xiang J, Ye Z, Chen W, Yang J. 2010. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo. Cancer Invest 28(1):85-93.
27. Yang BX, Duan YJ, Dong CY, Zhang F, Gao WF, Cui XY, Lin YM, Ma XT. 2011. Novel functions for mda-7/IL-24 and IL-24 delE5: regulation of differentiation of acute myeloid leukemic cells. Mol Cancer Ther 10(4):615-625.
28. Zheng M, Bocangel D, Ramesh R, Ekmekcioglu S, Poindexter N, Grimm EA, Chada S. 2008. Interleukin-24 overcomes temozolomide resistance and enhances cell death by downregulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. Mol Cancer Ther 7(12):3842-3851.